SAA1 and metabolomic signatures predict hyperprogression with immunotherapy in pan cancers.
Wang X, Zhang L, Liao L, Li N, Tang T, Sun J, Zhou Z, Liu Y, Huang J, Wang Y, Chen Z, Zhang H, Xiao T, Tian Y, Zheng X, Yuan Y, Xiao L, Liu L, Guan J.
Wang X, et al. Among authors: liu y, liu l.
Clin Transl Med. 2024 Mar;14(3):e1624. doi: 10.1002/ctm2.1624.
Clin Transl Med. 2024.
PMID: 38468504
Free PMC article.
No abstract available.